Cook Pharmica has signed an agreement with its first client, Monsanto Co., to perform small-scale manufacturing of bacterial-produced proteins in support of safety assessments of biotechnology-based crops. Cook Pharmica will perform the manufacturing at its Bloomington, IN facility. Terms of the agreement were not disclosed. “Cook Pharmica is pleased to be partnering with Monsanto and honored to be selected as their contract manufacturer,” said Jerry Arthur, president of Cook Ph...